Morgan Stanley’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.72M Buy
2,761,591
+828,186
+43% +$1.71M ﹤0.01% 3951
2025
Q1
$4.25M Sell
1,933,405
-860,785
-31% -$1.89M ﹤0.01% 4062
2024
Q4
$4.28M Buy
2,794,190
+1,025,837
+58% +$1.57M ﹤0.01% 4128
2024
Q3
$3.52M Buy
1,768,353
+1,000,492
+130% +$1.99M ﹤0.01% 4234
2024
Q2
$2.69M Buy
767,861
+568,862
+286% +$1.99M ﹤0.01% 4360
2024
Q1
$551K Sell
198,999
-725,297
-78% -$2.01M ﹤0.01% 5273
2023
Q4
$1.57M Buy
924,296
+488,789
+112% +$831K ﹤0.01% 5067
2023
Q3
$449K Buy
435,507
+58,237
+15% +$60K ﹤0.01% 5221
2023
Q2
$438K Sell
377,270
-78,727
-17% -$91.3K ﹤0.01% 5286
2023
Q1
$689K Sell
455,997
-355,904
-44% -$537K ﹤0.01% 5069
2022
Q4
$2.03M Sell
811,901
-134,412
-14% -$336K ﹤0.01% 4452
2022
Q3
$3.99M Sell
946,313
-1,091,582
-54% -$4.61M ﹤0.01% 3881
2022
Q2
$5.69M Buy
2,037,895
+567,067
+39% +$1.58M ﹤0.01% 3647
2022
Q1
$8.41M Buy
1,470,828
+1,178,629
+403% +$6.74M ﹤0.01% 3115
2021
Q4
$2.67M Sell
292,199
-72,570
-20% -$662K ﹤0.01% 4343
2021
Q3
$3.9M Sell
364,769
-155,629
-30% -$1.66M ﹤0.01% 3982
2021
Q2
$8.08M Sell
520,398
-98,330
-16% -$1.53M ﹤0.01% 3246
2021
Q1
$10M Buy
618,728
+158,965
+35% +$2.58M ﹤0.01% 2648
2020
Q4
$9.73M Buy
459,763
+271,879
+145% +$5.75M ﹤0.01% 2532
2020
Q3
$2.78M Buy
187,884
+96,089
+105% +$1.42M ﹤0.01% 3341
2020
Q2
$1.35M Sell
91,795
-429,386
-82% -$6.31M ﹤0.01% 3934
2020
Q1
$6.12M Buy
521,181
+325,758
+167% +$3.82M ﹤0.01% 2257
2019
Q4
$4.59M Buy
195,423
+127,508
+188% +$3M ﹤0.01% 3288
2019
Q3
$1.26M Buy
67,915
+29,977
+79% +$555K ﹤0.01% 4152
2019
Q2
$705K Sell
37,938
-26,308
-41% -$489K ﹤0.01% 4427
2019
Q1
$1.57M Sell
64,246
-365,531
-85% -$8.94M ﹤0.01% 3785
2018
Q4
$11.1M Buy
429,777
+262,171
+156% +$6.8M ﹤0.01% 2017
2018
Q3
$5.31M Sell
167,606
-196,396
-54% -$6.22M ﹤0.01% 3132
2018
Q2
$14.1M Buy
364,002
+213,862
+142% +$8.31M ﹤0.01% 1996
2018
Q1
$4.14M Buy
150,140
+11,464
+8% +$316K ﹤0.01% 3218
2017
Q4
$2.51M Buy
138,676
+66,633
+92% +$1.21M ﹤0.01% 3831
2017
Q3
$1.16M Sell
72,043
-29,030
-29% -$469K ﹤0.01% 4330
2017
Q2
$1.4M Buy
101,073
+1,040
+1% +$14.4K ﹤0.01% 4109
2017
Q1
$1.5M Sell
100,033
-56,840
-36% -$853K ﹤0.01% 4055
2016
Q4
$2.05M Buy
156,873
+72,859
+87% +$954K ﹤0.01% 3906
2016
Q3
$1.45M Buy
84,014
+61,210
+268% +$1.05M ﹤0.01% 3751
2016
Q2
$411K Buy
22,804
+13,546
+146% +$244K ﹤0.01% 4542
2016
Q1
$175K Sell
9,258
-42,915
-82% -$811K ﹤0.01% 5053
2015
Q4
$1.39M Sell
52,173
-26,324
-34% -$703K ﹤0.01% 3798
2015
Q3
$1.92M Sell
78,497
-150,465
-66% -$3.67M ﹤0.01% 3554
2015
Q2
$7.14M Sell
228,962
-59,840
-21% -$1.86M ﹤0.01% 2455
2015
Q1
$4.2M Buy
288,802
+267,192
+1,236% +$3.89M ﹤0.01% 2910
2014
Q4
$217K Buy
21,610
+17,872
+478% +$179K ﹤0.01% 5196
2014
Q3
$32K Sell
3,738
-3,107
-45% -$26.6K ﹤0.01% 5861
2014
Q2
$84K Sell
6,845
-109,916
-94% -$1.35M ﹤0.01% 5571
2014
Q1
$1.62M Buy
+116,761
New +$1.62M ﹤0.01% 3608